PIK3CA and laryngeal carcinoma: PIK3CA (H1047R) mutation was more frequent in laryngeal carcinomas (20%, 8 cases in larynx vs 6%, 2 cases in hypopharynx) and was significantly associated with stage I-II tumors (P = 0.002), and negative lymph node metastasis (P = 0.003).